Antibiotics maker Melinta files for Chapter 11 bankruptcy - Reuters

12/27/19

Antibiotics maker Melinta files for Chapter 11 bankruptcy Reuters
Melinta Therapeutics stock slides after company files for chapter 11 bankruptcy protection MarketWatch
Melinta Therapeutics Shares Drop After Company Files for Chapter 11 Wall Street Journal
Melinta files for Chapter 11, enters RSA with lenders Seeking Alpha
Melinta Therapeutics (MLNT) initiates voluntary proceedings under Chapter 11 of US Bankruptcy Code StreetInsider.com
View full coverage on Google News

[more]

Feeds Categories:
- Reorganizations,
- News